Frontiers in Pediatrics (Jul 2021)
Real-World Analysis of Survival and Clinical Events in a Cohort of Italian Perinatally HIV-1 Infected Children From 2001 to 2018
- Elena Chiappini,
- Elena Chiappini,
- Francesca Larotonda,
- Francesca Larotonda,
- Catiuscia Lisi,
- Catiuscia Lisi,
- Vania Giacomet,
- Paola Erba,
- Stefania Bernardi,
- Paola Zangari,
- Antonio Di Biagio,
- Lucia Taramasso,
- Carlo Giaquinto,
- Osvalda Rampon,
- Clara Gabiano,
- Silvia Garazzino,
- Claudia Tagliabue,
- Susanna Esposito,
- Eugenia Bruzzese,
- Raffaele Badolato,
- Domenico Zanaboni,
- Monica Cellini,
- Maurizio Dedoni,
- Antonio Mazza,
- Andrea Pession,
- Anna Maria Giannini,
- Filippo Salvini,
- Icilio Dodi,
- Ines Carloni,
- Salvatore Cazzato,
- Pier Angelo Tovo,
- Maurizio de Martino,
- Maurizio de Martino,
- Luisa Galli,
- Luisa Galli
Affiliations
- Elena Chiappini
- Paediatric Infectious Diseases Unit, Department of Health Sciences, Anna Meyer Children's Hospital, University of Florence, Florence, Italy
- Elena Chiappini
- Department of Paediatric Medicine, Anna Meyer Children's Hospital, University of Florence, Florence, Italy
- Francesca Larotonda
- Paediatric Infectious Diseases Unit, Department of Health Sciences, Anna Meyer Children's Hospital, University of Florence, Florence, Italy
- Francesca Larotonda
- Department of Paediatric Medicine, Anna Meyer Children's Hospital, University of Florence, Florence, Italy
- Catiuscia Lisi
- Paediatric Infectious Diseases Unit, Department of Health Sciences, Anna Meyer Children's Hospital, University of Florence, Florence, Italy
- Catiuscia Lisi
- Department of Paediatric Medicine, Anna Meyer Children's Hospital, University of Florence, Florence, Italy
- Vania Giacomet
- Paediatric Infectious Diseases Unit, Department of Paediatrics, Luigi Sacco Hospital, University of Milan, Milan, Italy
- Paola Erba
- Paediatric Infectious Diseases Unit, Department of Paediatrics, Luigi Sacco Hospital, University of Milan, Milan, Italy
- Stefania Bernardi
- Unit of Immune and Infectious Diseases, Stefania Bernardi Academic Department of Pediatrics (DPUO), Bambino Gesù Children's Hospital, Istituti di Ricovero e Cura a Carattere Scientifico, Rome, Italy
- Paola Zangari
- Research Unit of Clinical Immunology and Vaccinology, Paola Zangari Academic Department of Pediatrics (DPUO), Bambino Gesù Children's Hospital, Istituti di Ricovero e Cura a Carattere Scientifico, Rome, Italy
- Antonio Di Biagio
- Infectious Diseases Unit, Policlinico San Martino Hospital, University of Genova, Genoa, Italy
- Lucia Taramasso
- Infectious Diseases Unit, Policlinico San Martino Hospital, University of Genova, Genoa, Italy
- Carlo Giaquinto
- Department of Women and Child Health, University of Padova, Padua, Italy
- Osvalda Rampon
- Department of Women and Child Health, University of Padova, Padua, Italy
- Clara Gabiano
- Paediatric Infectious Diseases Unit, Regina Margherita Children's Hospital, University of Turin, Turin, Italy
- Silvia Garazzino
- Paediatric Infectious Diseases Unit, Regina Margherita Children's Hospital, University of Turin, Turin, Italy
- Claudia Tagliabue
- Paediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, Istituti di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico Foundation, University of Milan, Milan, Italy
- Susanna Esposito
- 0Paediatric Department, Pietro Barilla Children's Hospital, University of Parma, Parma, Italy
- Eugenia Bruzzese
- 1Paediatric Unit, Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy
- Raffaele Badolato
- 2Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
- Domenico Zanaboni
- 3Department on Internal Medicine and Therapeutics, Istituti di Ricovero e Cura a Carattere Scientifico Policlinico “S. Matteo” Foundation, University of Pavia, Pavia, Italy
- Monica Cellini
- 4Paediatric Hemato-Oncology Unit, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy
- Maurizio Dedoni
- 5Department of Paediatrics, Ospedale Microcitemico, Cagliari, Italy
- Antonio Mazza
- 6Department of Paediatrics, “S. Chiara” Hospital, Trento, Italy
- Andrea Pession
- 7Paediatric Unit, IRCCS Scientific Institute for Research and Healthcare, Sant'Orsola Hospital, Bologna, Italy
- Anna Maria Giannini
- 8Paediatric Infectious Diseases Unit, University Hospital Policlinico Giovanni XXIII, Bari, Italy
- Filippo Salvini
- 9Department of Paediatrics, Niguarda Hospital, University of Milan, Milan, Italy
- Icilio Dodi
- 0Department of Medicine and Surgery, Pietro Barilla Children's Hospital, University of Parma, Parma, Italy
- Ines Carloni
- 1Department of Mother and Child Health, Salesi Children's Hospital, Ancona, Italy
- Salvatore Cazzato
- 1Department of Mother and Child Health, Salesi Children's Hospital, Ancona, Italy
- Pier Angelo Tovo
- Paediatric Infectious Diseases Unit, Regina Margherita Children's Hospital, University of Turin, Turin, Italy
- Maurizio de Martino
- Paediatric Infectious Diseases Unit, Department of Health Sciences, Anna Meyer Children's Hospital, University of Florence, Florence, Italy
- Maurizio de Martino
- Department of Paediatric Medicine, Anna Meyer Children's Hospital, University of Florence, Florence, Italy
- Luisa Galli
- Paediatric Infectious Diseases Unit, Department of Health Sciences, Anna Meyer Children's Hospital, University of Florence, Florence, Italy
- Luisa Galli
- Department of Paediatric Medicine, Anna Meyer Children's Hospital, University of Florence, Florence, Italy
- DOI
- https://doi.org/10.3389/fped.2021.665764
- Journal volume & issue
-
Vol. 9
Abstract
Background: Combined antiretroviral therapy (cART) has been associated with a steep decrease in mortality and morbidity in HIV-1 infected children. New antiretroviral molecules and drug classes have been developed and the management of HIV-infected children has improved, but recent data on survival are limited.Methods: An observational retrospective study investigating changes in mortality and morbidity was conducted on 1,091 perinatally HIV-1 infected children enrolled in the Italian Register for HIV Infection in Children and followed-up from 2001 to 2018.Results: Three hundred and fifty-four (32%) AIDS events and 26 (2%) deaths occurred overtime. Mortality rates decreased from 0.4/100 person-years in 2001–2006 to 0.27/100 person-years in 2007–2012 and 0.07/100 person-years in 2013–2018. Notably, 92% of the dead children were born in Italy, but only 50% were followed-up since birth or within three months of age. Seventy three percent of children had started cART at age ≥6 months; 23% were treated for <30 days before death. B and C clinical events progressively decreased (P < 0.0001). Opportunistic infections significantly decreased over time, but still were the most common events in all the periods (6.76/100 person-years in 2013–2018). In the last period, severe bacterial infections were the most common ones. Cancer rates were 0.07/100; 0.17/100; 0.07/100 person-years in the three periods, respectively.Conclusions: Progressive reductions both in mortality and in rates of class B and C clinical events and OIs have been observed during the cART era. However, deaths were still registered; more than half of dead children were enrolled after birth and had belatedly started cART.
Keywords